CAPN13-GALNT14 Fusion FISH Probe
The CAPN13-GALNT14 Fusion FISH Probe is used to confirm a fusion of the CAPN13 and GALNT14 genes. The fusion of the CAPN13 and GALNT14 genes has been associated with Lung Adenocarcinoma, and Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CAPN13-GALNT14-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CAPN13-GALNT14-20-AQAQ | 20 (40 μL) | 200 μL |
|
GALNT14 Gene Summary
This gene encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. These enzymes catalyze the transfer of N-acetyl-D-galactosamine (GalNAc) to the hydroxyl groups on serines and threonines in target peptides. The encoded protein has been shown to transfer GalNAc to large proteins like mucins. Alterations in this gene may play a role in cancer progression and response to chemotherapy. [provided by RefSeq, Jun 2016]
Gene Name: Polypeptide N-acetylgalactosaminyltransferase 14
Chromosome: CHR2: 31133332 -31361571
Locus: 2p23.1
CAPN13 Gene Summary
The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes a member of the calpain large subunit family. [provided by RefSeq, Jun 2012]
Gene Name: Calpain 13
Chromosome: CHR2: 30945637 -31030311
Locus: 2p23.1
Gene Diseases
The CAPN13 GALNT14 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|